News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Thanks to a unique public-private partnership, new data elements will soon be a routine part of electronic health records, capturing information about cancer and helping to improve cancer diagnosis, treatment, and care.

Hear the latest in digital twin development, technologies, and applications at Bio-IT World Conference and Expo.

Read the four-part series on NCI’s Cancer Research Data Commons’ history, resources, standards, and future initiatives. The articles are now available online in “Cancer Research,” one of the flagship journals of the American Association for Cancer Research (AACR).

NIH Institutes and Centers (including NCI) are interested in the validity, reliability, and utility of digital health tools and artificial intelligence/machine learning (AI/ML) technologies. You can apply for NCI funding to support the validation of these technologies for cancer research.

Find harmonized demographic and clinical data in this new data commons from NCI’s Childhood Cancer Data Initiative!

Learn about the latest programs in NCI’s Childhood Cancer Data Initiative. A newly published summary offers an update on what’s underway and a forecast for future research.

Attending the AMIA 2024 Informatics Summit? Don't miss these NCI CBIIT-affiliated data science sessions!

Are you planning to attend this year’s American Association for Cancer Research (AACR) Annual Meeting? Make sure to add these NCI-affiliated data science activities to your schedule!

Learn more about the team that won the 2023 DataWorks! Challenge Grand Prize. The winners crowdsourced data gathering and used a common, interoperable platform to understand the impacts of COVID-19 on people with a current or past history of cancer.

Are you having trouble prioritizing which genetic variants to study in your cancer research? There’s a new platform, called FORGEdb, that can help you pinpoint promising variants and target genes.